Analyst Ratings for Bright Minds Biosciences Inc. (DRUG)
DRUG Rating Summary
DRUG Price Target Summary
- Highest: $220.00 (Piper Sandler)
- Lowest: $126.00 (Baird)
- Average: $156.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$156.60 (+158.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$156.60 (+158.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/13/2026 | Jefferies | Andrew Tsai | New Coverage | Buy (N/A) |
145.00 (N/A) |
85.91 (60.66) |
-29.39% | Details |
| 9/8/2025 | BTIG » Updated 3/30/2026 |
Thomas Shrader | New Coverage | Buy (N/A) |
147.00 (N/A) |
42.24 (60.66) |
43.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
